What development phase is Mecadox in?

Mecadox is FDA-approved (marketed).

What is the generic name of Mecadox?

CARBADOX is the generic (nonproprietary) name of Mecadox.

Last reviewed 2026-04-20 · How we verify

Mecadox (CARBADOX)

FDA-approved active Small molecule Quality 6/100

CARBADOX (Mecadox) is a marketed antimicrobial agent that inhibits the growth of certain bacteria and other microorganisms. A key strength is its composition patent, which is set to expire in 2028, providing a period of market exclusivity. The primary risk is the potential increase in competition following the patent expiry in 2028.

At a glance

Generic name	CARBADOX
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Mecadox CI brief — competitive landscape report
Mecadox updates RSS · CI watch RSS